StockData
Moderna, Inc. logo

Moderna, Inc.

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30567% above fair value
$220.83−0.89 (-0.40%)

Close on Nov 2, 2026Market cap $88.16BP/E –Yield –

Moderna Losses on firm purchase commitments & CMO cancellation by Quarter

Losses on firm purchase commitments & CMO cancellation fees ($M) ($M)

QuarterlyAnnual

Moderna Losses on firm purchase commitments & CMO cancellation: $0M in Q2 2026, down 100.0% from a year earlier. That is the lowest of the 21 quarters on record here.

Latest, Q2 2026
0
Period ended Jun 30, 2026
Change on a year earlier
-100.0%
7 in Q2 2025
History
21 quarters
Since Q2 2021
Sources
16
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-07-31) ↗

Reported in Form 10-Q / 10-K Note 6 (Inventory & Purchase Commitments).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLosses on firm purchase commitments & CMO cancellation fees ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20260-100.0%Form 10-Q (filed 2026-07-31) ↗
Q1 2026Mar 31, 20260-100.0%Form 10-Q (filed 2026-05-01) ↗
Q4 2025Dec 31, 20250-100.0%Form 10-K (filed 2026-02-20) ↗
Q3 2025Sep 30, 20257-66.7%Form 10-Q (filed 2025-11-06) ↗
Q2 2025Jun 30, 20257–Form 10-Q (filed 2026-07-31) ↗
Q1 2025Mar 31, 202510–Form 10-Q (filed 2026-05-01) ↗
Q4 2024Dec 31, 202439–Form 10-K (filed 2026-02-20) ↗
Q3 2024Sep 30, 202421–Form 10-Q (filed 2025-11-06) ↗
Q2 2024Jun 30, 20240-100.0%Form 10-Q (filed 2025-08-01) ↗
Q1 2024Mar 31, 20240-100.0%Form 10-Q (filed 2025-05-01) ↗
Q4 2023Dec 31, 20230-100.0%Form 10-K (filed 2026-02-20) ↗
Q3 2023Sep 30, 20230-100.0%Form 10-Q (filed 2024-11-07) ↗
Q2 2023Jun 30, 202375-59.2%Form 10-Q (filed 2024-08-01) ↗
Q1 2023Mar 31, 202366-58.5%Form 10-Q (filed 2024-05-02) ↗
Q4 2022Dec 31, 2022268–Form 10-K (filed 2025-02-21) ↗
Q3 2022Sep 30, 20227–Form 10-Q (filed 2023-11-03) ↗

Cite this data

StockData. (2026). Moderna Losses on firm purchase commitments & CMO cancellation ($M), quarterly Q2 2021–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/cos-firm-commit-loss

See every metric in the Moderna KPI table. Data updated Nov 3, 2026.